INTRABEAM® Intraoperative Radiation Therapy
Memorial University Medical Center was the first in Georgia to offer INTRABEAM® intraoperative radiation therapy (IORT) for breast cancer.
INTRABEAM delivers radiation directly into the tumor bed during breast-conserving surgery to kill cancer cells, shorten treatment time, and prevent recurrence. For some women, IORT eliminates the need for six weeks of radiation therapy after surgery. For others, it can shorten radiation treatment time by up to seven days.
The INTRABEAM delivery system was studied in an international randomized controlled clinical trial called TARGIT-A. The trial compared INTRABEAM to standard external radiation treatment.
The TARGIT study found that 85 percent of women who received IORT did not need additional radiation treatment after the procedure. For the 15 percent who did need additional whole breast radiation therapy, the IORT served as a "boost" dose and cut five to seven days off of their post-surgery treatment.
Because IORT delivers radiation directly into the tumor bed, there is less damage to surrounding healthy tissue and less chance of a cancer recurrence.
As Seen on TV
Gale Brill, breast cancer survivor, was the first in Georgia to receive INTRABEAM IORT. She shares her thoughts on the technology.
Just days after being diagnosed with breast cancer, Eileen Healy learned her daughter also had the disease. Hear her story.
Sandy Jones, breast cancer survivor, talks about her diagnosis and using IORT as a radiation "boost" treatment.
Patricia Singleton, breast cancer survivor, talks about how INTRABEAM IORT saved her life.
Yvonne Trapnell, breast cancer survivor, talks about faith, family, and her decision to have IORT.